BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Thursday, June 4, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 27, 2013
View Archived Issues
A proof of principle study of a predictive biomarker-based blood test for suicide risk
Read More
Preclinical validation of a first-in-class p53 pathway reactivator for the treatment of cancer
Read More
Demonstration of an effective cure for symptomatic Ebola virus infection
Read More
Lumena begins patient recruitment for CLARITY and IMAGO
Read More
New FSH-R agonists discovered by Merck KGaA
Read More
Novel TLR7/TLR8 receptor agonists disclosed by Janssen R&D Ireland
Read More
Researchers at Lupin synthesize new agents for HCV infection
Read More
Chinese researchers prepare novel tyrosine-protein kinase inhibitors
Read More
New P2X receptor antagonists described by Shionogi & Co.
Read More
New adenoviral vector with enhanced immunogenicity against HCV
Read More
ReNeuron's retinal stem cell therapy receives orphan drug status
Read More
Sanofi Pasteur reports topline data for Fluzone High-Dose vaccine
Read More
CP-9531 shows promising efficacy and safety in vivo
Read More
KemPharm reports data from KP-201 study
Read More
Alcobra enrolls first patient in predominantly inattentive ADHD study
Read More
Ultragenyx Pharmaceutical's triheptanoin IND is now active
Read More
Oragenics reports data from lantibiotics program
Read More
Japan's MHLW Drug Committee endorses QVA-149 approval
Read More
FDA approves first topical therapy for erythema in patients with rosacea
Read More
Takeda and Zinfandel begin phase III trial to delay MCI in Alzheimer's disease
Read More
Rigel to discontinue R-343 development
Read More
FDA grants priority review to Nexavar sNDA in RAI-refractory differentiated thyroid cancer
Read More
Sangamo BioSciences signs definitive agreement to acquire Ceregene
Read More
Lipidor's phase I/II trial of Akvano/calcipotriol spray meets primary endpoint
Read More
